172 related articles for article (PubMed ID: 12876553)
1. [Reflections on the treatment of EDM in hepatitis C virus patients treated with interferon alpha from a retrospective survey concerning 29 patients].
Lang JP; Halleguen O; Vecchionacci V; Doffoel M
Encephale; 2003; 29(3 Pt 1):273-7. PubMed ID: 12876553
[TBL] [Abstract][Full Text] [Related]
2. [Benefits of a preventive psychiatric accompaniment in patients Hepatitis C Virus seropositive (HCV): prospective study concerning 39 patients].
Lang JP; Meyer N; Doffoel M
Encephale; 2003; 29(4 Pt 1):362-5. PubMed ID: 14615706
[TBL] [Abstract][Full Text] [Related]
3. [Alpha-interferon and mental disorders].
Debien C; De Chouly De Lenclave MB; Foutrein P; Bailly D
Encephale; 2001; 27(4):308-17. PubMed ID: 11686052
[TBL] [Abstract][Full Text] [Related]
4. Depression during therapy with interferon alpha--how long should an antidepressant treatment last?
Nickel T; Sonntag A; Backmund M; Pollmächer T
Pharmacopsychiatry; 2005 Mar; 38(2):102-4. PubMed ID: 15744637
[TBL] [Abstract][Full Text] [Related]
5. Lack of association of indoleamine 2,3-dioxygenase polymorphisms with interferon-alpha-related depression in hepatitis C.
Galvão-de Almeida A; Quarantini LC; Sampaio AS; Lyra AC; Parise CL; Paraná R; de Oliveira IR; Koenen KC; Miranda-Scippa A; Guindalini C
Brain Behav Immun; 2011 Oct; 25(7):1491-7. PubMed ID: 21693183
[TBL] [Abstract][Full Text] [Related]
6. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
Cacoub P; Lidove O; Maisonobe T; Duhaut P; Thibault V; Ghillani P; Myers RP; Leger JM; Servan J; Piette JC
Arthritis Rheum; 2002 Dec; 46(12):3317-26. PubMed ID: 12483738
[TBL] [Abstract][Full Text] [Related]
7. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
[TBL] [Abstract][Full Text] [Related]
8. Major depressive disorder with psychotic features induced by interferon-alpha treatment for hepatitis C in a polydrug abuser.
Kalyoncu OA; Tan D; Mirsal H; Pektas O; Beyazyurek M
J Psychopharmacol; 2005 Jan; 19(1):102-5. PubMed ID: 15671136
[TBL] [Abstract][Full Text] [Related]
9. [Cross-sectional study of the prevalence of adjustment disorder with anxiety in general practice].
Semaan W; Hergueta T; Bloch J; Charpak Y; Duburcq A; Le Guern ME; Alquier C; Rouillon F
Encephale; 2001; 27(3):238-44. PubMed ID: 11488254
[TBL] [Abstract][Full Text] [Related]
10. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups.
Schaefer M; Schmidt F; Folwaczny C; Lorenz R; Martin G; Schindlbeck N; Heldwein W; Soyka M; Grunze H; Koenig A; Loeschke K
Hepatology; 2003 Feb; 37(2):443-51. PubMed ID: 12540795
[TBL] [Abstract][Full Text] [Related]
11. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and impact of manic traits in depressed patients initiating interferon therapy for chronic hepatitis C infection.
Lim C; Olson J; Zaman A; Phelps J; Ingram KD
J Clin Gastroenterol; 2010 Aug; 44(7):e141-6. PubMed ID: 20495465
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing long-term changes in mental health after interferon-alpha treatment of chronic hepatitis C.
Schmidt F; Janssen G; Martin G; Lorenz R; Loeschke K; Soyka M; Folwaczny C; Schaefer M
Aliment Pharmacol Ther; 2009 Nov; 30(10):1049-59. PubMed ID: 19691667
[TBL] [Abstract][Full Text] [Related]
14. Antiviral therapy for hepatitis C virus recurrence following liver transplantation: long-term results from a single center experience.
Burra P; Targhetta S; Pevere S; Boninsegna S; Guido M; Canova D; Brolese A; Masier A; D'Aloiso C; Germani G; Tomat S; Fagiuoli S
Transplant Proc; 2006 May; 38(4):1127-30. PubMed ID: 16757285
[TBL] [Abstract][Full Text] [Related]
15. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
Goeb JL; Coste J; Bigot T; Ferrand I
Encephale; 2000; 26(6):11-20. PubMed ID: 11217533
[TBL] [Abstract][Full Text] [Related]
16. [Suicide attempts of 48 children aged 6-12 years].
Berthod C; Giraud C; Gansel Y; Fourneret P; Desombre H
Arch Pediatr; 2013 Dec; 20(12):1296-305. PubMed ID: 24183875
[TBL] [Abstract][Full Text] [Related]
17. Interferon-alpha can be used successfully in patients with hepatitis C virus-positive chronic hepatitis who have a psychiatric illness.
Van Thiel DH; Friedlander L; Molloy PJ; Fagiuoli S; Kania RJ; Caraceni P
Eur J Gastroenterol Hepatol; 1995 Feb; 7(2):165-8. PubMed ID: 7712309
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up after successful interferon therapy of acute hepatitis C.
Wiegand J; Jäckel E; Cornberg M; Hinrichsen H; Dietrich M; Kroeger J; Fritsch WP; Kubitschke A; Aslan N; Tillmann HL; Manns MP; Wedemeyer H
Hepatology; 2004 Jul; 40(1):98-107. PubMed ID: 15239091
[TBL] [Abstract][Full Text] [Related]
19. [Acute hepatitis C: response to treatment with interferon-alpha plus ribavirin].
Vega Palomares R; Planas Vilà R; Durández Lazaro R; Fábregas Puigtió S
Gastroenterol Hepatol; 2002 Oct; 25(8):483-6. PubMed ID: 12361528
[TBL] [Abstract][Full Text] [Related]
20. [Prevalence of depressive disorders in children and adolescents attending primary care. A survey with the Aquitaine Sentinelle Network].
Mathet F; Martin-Guehl C; Maurice-Tison S; Bouvard MP
Encephale; 2003; 29(5):391-400. PubMed ID: 14615688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
